Check your doctor's credentials, education and standing with the Texas Medical Board
Dr. Prakash K. Desai’s practice at the Amarillo Heart Group includes electrophysiology studies, radio frequency ablation of arrhythmias, pharmacological management of cardiac arrhythmia, temporary/ permanent pacemaker and defibrillator implantation, and syncope evaluation. Dr. Desai has served as chief of cardiology for BSA Healthcare System and medical director of the Pacemaker/ICD Clinic at Amarillo Heart Group. He pioneered electrophysiology services in Amarillo in 1994, and has been investigator for numerous clinical research trials for pacemaker and ICD devices. Dr. Desai is board certified in internal medicine and cardiovascular disease.
Texas Super Doctors 2020
Texas Super Doctors 2019
Texas Super Doctors 2018
Texas Super Doctors 2017
Texas Super Doctors 2016
Texas Super Doctors 2015
Texas Super Doctors 2014
Texas Super Doctors 2013
Texas Super Doctors 2012
Texas Super Doctors 2011
Texas Super Doctors 2010
Medical School: B.J. Medical College
Graduation Year: 1982
Professional Webpage: www.amarilloheartgroup.com/physicians/dr_desai.htm
*** Increase of Vagal Tone in Chronic Heart Failure (INOVATE-HF) -
***Nanostim: Leadless pacemaker investigation, St, Jude Medical
***BOOST: Benefit of Frequent Optimization after Cardiac
***Resynchronization Therapy Device ReplacemenT
***ACUITY: Longitudinal Surveillance Registry of the ACUITY™ Spiral Lead LSR of ACUITY Spiral
***PACE-MI Registry: Pacemaker and Beta-blocker Therapy post MI
***CELESTIAL Post Approval Registry: Corox OTW, Endocardial. Left Ventricular Steroid Lead, Bipolar Post Approval Registry
***GALAXY Registry: LonG-Term EvALuAtion of the LinoX FamilY ICD Leads Registry
*** RISK - Stratification Using a Combination of Cardiac Troponin T and Brain Natriuretic Peptide in Patients Receiving CRT-D
***ULTRA: Ventricular Automatic Capture Assessment
***Phase I GDT1000 Sensing Acute Human Study PROJECT
***EASY-TRAK EPI Bi ventricular ICD lead study
***EASY-TRAK®4 Steerable LV Lead
***RIGHT ID Going Head to Head Study (RIGHT)
***Post Approval Study (PAS)
***Multi-Center Automatic Defibrillator Implantation Trial with CRT (MADIT-CRT)
***Analysis of a New AT/AF Detection Algorithmic in Patients with Atrial Arrhythmia (AWARE)
***ASPEN-ICD: AF Suppression Pacing to Prevent First Episode of
***Atrial Fibrillation in High Risk Patients with an Implantable Cardioverter Defibrillator
***Primary Prevention Parameters Evaluation (PREPARE)
***Microvolt T-wave Alternans Testing for Risk Stratification for Post MI Patients (MASTER)
***Stimulation Therapy Overdrives Paroxysmal AF in Dual Chamber ICD Patients. STOP-AF
***Reported Atrial Fibrillation and Inappropriate Mode Switch in Sick Sinus Syndrome Patients(. RARE)
***Rhythm ICD Trial
***MORPHOLOGY: Morphology Discrimination: Effect of High Rate Atrial Pacing on Template Matching
***A Clinical Evaluation to Document Appropriate Performance of the VENTAK PRlZM AVT (Model 1900) Automatic Implantable Cardioverter Defibrillator System.
***Evaluation of Atrial Arrhythmias Utilizing the Onset of Electrogram
***Capability of Discovery II and VENTAK PRlZM AlCD Field Following
***Tachos Atrial Conversion Therapy (TACTClinical investigation)
***Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION)
***Medtronic DX2 Pacemaker 1st Dual Sensing Pacemaker IDE Clinical Trial
***Medtronic 6932 RV ICD Lead Clinical Trial
***4215, 4211 Guardian Telectronics ICD Clinical Trial
***RES-Q Micron ICD Clinical Trial
*** MultiPoint Pacing (MPP) IDE Study (MPP)- MPP IDE Study is a
prospective, randomized, double-blinded, multicenter, pivotal study to
evaluate the safety and effectiveness of the Quadripolor CRT-D device
system (MPP feature) when compared to standard BiV pacing in patients
that are indicated for CRT-D device.
***ST monitoring to Detect ACS Events in ICD Patients Study (Analyze ST)
***Risk Estimation Following Infarction, Non-invasive Evaluation - ICD efficacy (REFINE ICD)
***A Placebo-Controlled, Double-Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400 mg bid for the Prevention of Cardiovascular Hospitalization or Death From Any Cause in Patients with Atrial Fibrillation/Atrial Flutter (AF/AFL)
***IMPROVE-IT ( sub investigator)
IMProved Reduction of Outcomes: Vytorin Efficacy International Trial- A Multicenter, Double-Blind, Randomized Study to Establish the Clinical Benefit and Safety of Vytorin (Ezetimibe/Simvastatin Tablet) vs Simvastatin Monotherapy in High-Risk Subjects Presenting with Acute Coronary Syndrome)
***Pacing Evaluation Atrial Support Study in CRT (PEGASUS)
Compatibility of the PCD Transvene System with Unipolar DDD
Pacemakers Presentation at CARDlOSTlM 94, 9th International
Total Lung Capacity Can Predict Unsuccessful Nonthoracotomy
Defibrillator Implant North American Society of Pacing and
Electrophysiology (NASPE) Pace May 1994.
Is Patch Position Critical for Successful Nonthoracotomy (NTL) ICD Implant with Biphasic Shock? Abstract: American Heart
Association1993, Circulation Nov. 1993.
Single path Biphasic Defibrillation using Transvenous Leads is as
effective as Dual path Monophasic Defibrillation; Abstract:
North American Society of Pacing and Electrophysiology (NASPE): PACE May 1993.
Left Main Coronary Artery Aneurysm, A case report and review of
literature; Catheterization and Cardiovascular Diagnosis: Nov. 1992.
Co-investigator for multicenter international trial of Survival with oral d-Sotalol (SWORD)
Active participation in double blind randomized evaluation of
Propafenone on defibrillation thresholds in patients with ICD's, New England Area Atrial Fibrillation Trial (NAFiT)
Evaluating atrial fibrillation using transvenous leads with new PCD 7219 Jewel
Hartford Center for Medical Research: Clinical trials of new cardiac drugs.
Circadian Rhythm of Total and Differential Leucocyte Count"
International Journal of Chronobiology, Vol 7, 1981
Super Doctors identifies top doctors as selected by their peers and the independent research of MSP Communications.
Super Doctors is published online and also in print as a special advertising section in leading newspapers and city and regional magazines.